Human Alpha1-Proteinase Inhibitor
Products Human alpha1-proteinase inhibitor was approved in many countries in 2016 as a powder and solvent for the preparation of an intravenous infusion solution (Respreeza, USA: Zemaira). It has been approved in the United States since 2003 and in the EU since 2015. Structure and properties Human alpha1-proteinase inhibitor is a glycoprotein derived from human … Human Alpha1-Proteinase Inhibitor
